Closer adherence urged to improve AMD outcomes
Closer adherence to published protocols and more aggressive treatment of patients with neovascular age-related macular degeneration (AMD) could help to improve visual outcomes in these patients, according to Frank Holz MD.
Presenting data from the AURA study, an international retrospective analysis of the real-world utilisation of anti-VEGF therapy in neovascular AMD, Dr Holz told delegates attending the 13th EURETINA Congress that the clinical endpoints of the study were to evaluate changes in visual acuity and resource utilisation in terms of overall visits, visual acuity and OCT tests and treatment use, following anti-VEGF treatment.
Data from 2,227 patients were collated from centres in Canada, France, Germany, Ireland, Italy, the Netherlands, UK and Venezuela.
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.